With the exception of lung cancer, the authors claim that the upregulation of HPRT is independent of cancer grade or stage, and they hypothesize that HPRT could be utilized as an early biomarker because it appears to be upregulated in cancer regardless of stage [159]. This evidence concerns the gene HPRT1 and cancer.